Faculty of Public Health, Universitas Ahmad Dahlan, Yogyakarta, Indonesia.
Faculty of Pharmacy, Universitas Ahmad Dahlan, Yogyakarta, Indonesia.
Front Public Health. 2023 Feb 28;11:1069422. doi: 10.3389/fpubh.2023.1069422. eCollection 2023.
Breast cancer is one of the most important health problems worldwide. Quality of life (QoL) is an important indicator to evaluate symptoms in cancer patients, including those with breast cancer. Culturally suitable, valid, reliable, and appropriate instruments to measure the QoL of breast cancer patients are needed, which is still rare in Indonesia. This study aimed to translate the EORTC QLQ-BR45 instrument into Indonesian and evaluate its psychometrics.
A cross-sectional study was performed on 635 patients conveniently selected from the oncology department in referral hospital. The first phase of this study involved translation of the existing EORTC QLQ-BR45 into Indonesian, and in the second phase, we evaluated its psychometric properties. Construct validity was evaluated using confirmatory factor analysis (CFA). Criterion validity was examined according to the association between disease stage and Karnofsky Performance Scale (KPS).
A total of 635 (99.00%) completed the EORTC QLQ-BR45 successfully. The instrument indicated good readability and high content validity. All Cronbach's alpha coefficients were satisfactory (overall value, 0.87). For construct validity, patients with KPS ≥80% did better than those with KPS ≤70% as did two multi-item scales in functional scales (body image and breast satisfaction) and five multi-item scales in symptom scales (systemic therapy side effects, endocrine therapy, and arm, breast, and endocrine sexual symptoms). Body image score of late-stage patients was significantly higher. CFA indicated that the nine-factor structure of the Indonesian EORTC QLQ-BR45 was a good fit for the data.
The Indonesian EORTC QLQ-BR45 questionnaire is reliable and valid with good psychometric properties, thus can be used for breast cancer patients in Indonesia.
乳腺癌是全球最重要的健康问题之一。生活质量(QoL)是评估癌症患者症状的重要指标,包括乳腺癌患者。需要有适合文化背景、有效、可靠和适当的工具来衡量乳腺癌患者的生活质量,但印度尼西亚仍缺乏这种工具。本研究旨在将 EORTC QLQ-BR45 量表翻译成印度尼西亚语,并评估其心理测量学特性。
本研究采用横断面研究,方便选取来自转诊医院肿瘤内科的 635 名患者。本研究的第一阶段包括将现有的 EORTC QLQ-BR45 翻译成印度尼西亚语,第二阶段评估其心理测量学特性。结构效度采用验证性因子分析(CFA)进行评估。根据疾病阶段与 Karnofsky 表现量表(KPS)的相关性评估效标效度。
共有 635 名(99.00%)患者成功完成 EORTC QLQ-BR45。该量表具有良好的可读性和较高的内容效度。所有 Cronbach's alpha 系数均令人满意(总体值为 0.87)。在结构效度方面,KPS≥80%的患者比 KPS≤70%的患者表现更好,两个多项目量表(身体形象和乳房满意度)和五个多项目量表(全身治疗副作用、内分泌治疗以及手臂、乳房和内分泌性功能症状)在功能量表中表现更好。晚期患者的身体形象评分明显更高。CFA 表明,印度尼西亚 EORTC QLQ-BR45 的九因素结构对数据具有良好的拟合度。
印度尼西亚 EORTC QLQ-BR45 问卷具有良好的信度和效度,心理测量学特性良好,因此可用于印度尼西亚的乳腺癌患者。